English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/33149
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorCasanovas, Josep M.-
dc.contributor.authorVilaró, Maria Teresa-
dc.contributor.authorMengod Los Arcos, Guadalupe-
dc.contributor.authorArtigas, Francesc-
dc.date.accessioned2011-03-08T09:54:51Z-
dc.date.available2011-03-08T09:54:51Z-
dc.date.issued1999-01-
dc.identifier.citationJournal of Neurochemistry 72(1): 262–272 (1999)es_ES
dc.identifier.issn0022-3042-
dc.identifier.urihttp://hdl.handle.net/10261/33149-
dc.description.abstractSingle treatment with the serotonin (5-hydroxytryptamine) 5-HT1A receptor agonists 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and alnespirone (S-20499) reduces the extracellular 5-HT concentration (5-HText) in the rat midbrain and forebrain. Given the therapeutic potential of selective 5-HT1A agonists in the treatment of affective disorders, we have examined the changes in 5-HT1A receptors induced by 2-week minipump administration of alnespirone (0.3 and 3 mg/kg/day) and 8-OH-DPAT (0.1 and 0.3 mg/kg/day). The treatment with alnespirone did not modify baseline 5-HText but significantly attenuated the ability of 0.3 mg/kg s.c. alnespirone to reduce 5-HText in the dorsal raphe nucleus (DRN) and frontal cortex. In contrast, the ability of 8-OH-DPAT (0.025 and 0.1 mg/kg s.c.) to reduce 5-HText in both areas was unchanged by 8-OH-DPAT pretreatment. Autoradiographic analysis revealed a significant reduction of [3H]8-OH-DPAT and [3H]WAY-100635 {3H-labeled N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide · 3HCl} binding to somatodendritic 5-HT1A receptors (but not to postsynaptic 5-HT1A receptors) of rats pretreated with alnespirone but not with 8-OH-DPAT. In situ hybridization analysis revealed no change of the density of the mRNA encoding the 5-HT1A receptors in the DRN after either treatment. These data indicate that continuous treatment for 2 weeks with alnespirone, but not with 8-OH-DPAT, causes a functional desensitization of somatodendritic 5-HT1A receptors controlling 5-HT release in the DRN and frontal cortex.es_ES
dc.language.isoenges_ES
dc.publisherBlackwell Publishinges_ES
dc.rightsopenAccesses_ES
dc.subjectSerotonin 5-HT1A receptorses_ES
dc.subject5-Hydroxytryptamine (5-HT) releasees_ES
dc.subjectAnxietyes_ES
dc.subjectDepressiones_ES
dc.subjectDorsal raphe nucleuses_ES
dc.subjectFrontal cortexes_ES
dc.titleDifferential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat braines_ES
dc.typeartículoes_ES
dc.identifier.doi10.1046/j.1471-4159.1999.0720262.x-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1046/j.1471-4159.1999.0720262.x/pdfes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1046/j.1471-4159.1999.0720262.x-
dc.identifier.e-issn1471-4159-
Appears in Collections:(IIBB) Artículos
Files in This Item:
File Description SizeFormat 
j.1471-4159.1999.0720262.x.pdf359,58 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.